Learn more

RETROPHIN INC

Overview
  • Total Patents
    62
  • GoodIP Patent Rank
    33,001
  • Filing trend
    ⇩ 50.0%
About

RETROPHIN INC has a total of 62 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are KANEQ PHARMA INC, BILLER SCOTT A and ATLANTHERA.

Patent filings per year

Chart showing RETROPHIN INCs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Organic fine chemistry

Top inventors

# Name Total Patents
#1 Vaino Andrew 23
#2 Shkreli Martin 23
#3 Biestek Marek 23
#4 Elbaum Daniel 13
#5 Beconi Maria 13
#6 Malancona Savina 13
#7 Komers Radko 9
#8 Shih Alvin 7
#9 Macikenas Dainius 7
#10 Ruby Kale 7

Latest patents

Publication Filing date Title
WO2020132594A1 Amorphous sparsentan compositions
WO2020072814A1 Biphenyl sulfonamide compounds for the treatment of type iv collagen diseases
SG11201906811WA Solid fosmetpantotenate formulations
US2019262317A1 Biphenyl sulfonamide compounds for the treatment of kidney diseases or disorders
US2019337971A1 Pantetheine derivatives for the treatment of neurologic disorders
AU2016366977A1 Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders
WO2016138436A2 Tetracosactide complexed with zinc phosphate
US2016264607A1 Pantothenate derivatives for the treatment of neurological disorders
SI2841438T1 Pantothenate derivatives for the treatment of neurologic disorders